Retour
Fourchette du Jour
0,29 €
0,44 €
Fourchette 52 Semaines
0,29 €
0,44 €
Volume
130
Moyenne 50J / 200J
0,44 €
/
0,44 €
Clôture Précédente
0,44 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,7 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -651164,0 | 3,9 |
| Rev Growth 5Y % | -27,8 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
0,00 €
0,00 € – 0,00 €
|
150 M | 1 |
| FY2028 |
0,00 €
0,00 € – 0,00 €
|
64 M | 1 |
| FY2027 |
0,00 €
0,00 € – 0,00 €
|
200000 | 1 |
Points Clés
Revenue declined -27,80% annually over 5 years
Negative free cash flow of -158,66M
PEG of 0,05 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 52,15%
Capital intensive — 52,00% of revenue goes to capex
Croissance
Revenue Growth (5Y)
-27,80%
Revenue (1Y)-79,95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROICN/A
Net Margin-651164,00%
Op. Margin-623048,00%
Sécurité
Debt / Equity
N/A
Current Ratio0,22
Interest Coverage-3,35
Valorisation
P/E Ratio
-3,70
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -79,95% | Revenue Growth (3Y) | -60,61% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -27,80% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 25 000,0 | Net Income (TTM) | -162,79M |
| ROE | N/A | ROA | -286,61% |
| Gross Margin | 100,00% | Operating Margin | -623048,00% |
| Net Margin | -651164,00% | Free Cash Flow (TTM) | -158,66M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,22 |
| Interest Coverage | -3,35 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3,70 | P/B Ratio | N/A |
| P/S Ratio | 24076,41 | PEG Ratio | 0,05 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 601,91M | Enterprise Value | 553,47M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25 000,0 | 124 666,0 | 161 163,0 | 125 047,0 | 91 981,0 |
| Net Income | -162,79M | -220,24M | -211,88M | -127,99M | -60,79M |
| EPS (Diluted) | -0,13 | -0,35 | -0,45 | -0,34 | -0,18 |
| Gross Profit | 25 000,0 | 22 014,0 | -89 309,0 | -107 422,0 | -480 000,0 |
| Operating Income | -155,76M | -191,84M | -223,45M | -133,27M | -53,18M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 56,80M | 188,79M | 148,19M | 87,32M | 184,36M |
| Total Liabilities | 257,87M | 264,60M | 156,98M | 17,55M | 4,16M |
| Shareholders' Equity | -201,07M | -75,81M | -8,79M | 69,77M | 180,20M |
| Total Debt | 0,0 | 141,65M | 272 982,0 | 0,0 | 150 469,0 |
| Cash & Equivalents | 48,44M | 172,47M | 133,99M | 64,90M | 157,43M |
| Current Assets | 56,80M | 188,19M | 147,80M | 87,12M | 183,97M |
| Current Liabilities | 257,87M | 64,06M | 28,16M | 17,51M | 4,14M |